Candida albicans carries one of the stranger genomes in the fungal kingdom. It is an obligate diploid, meaning it maintains two copies of every chromosome with no known stable haploid state, and it uses a genetic code that deviates from the “universal” code shared by nearly all other life on earth. These quirks are not academic trivia. They shape how this organism causes disease, evades antifungal drugs, and outmaneuvers the human immune system, and they have made it an unusually tricky target for both laboratory research and clinical treatment.
A Diploid Genome With No Haploid Phase
Most organisms that scientists study genetically can be coaxed into a haploid state, where each chromosome exists as a single copy. That makes it straightforward to study what individual genes do, because there is no second copy to mask a mutation. Candida albicans does not cooperate. Its genome exists as a diploid, with two copies of each of its eight chromosomes, and no one has found a natural or laboratory condition that produces a stable haploid. The reference genome was sequenced from strain SC5314, a clinical isolate, using methods designed specifically to handle the fact that the two copies of each chromosome differ from one another at many positions.1PubMed Central. The diploid genome sequence of Candida albicans That pervasive heterozygosity, where the two chromosome copies carry different versions of the same gene, turns out to be functionally important rather than mere noise.
Compared to the well-studied baker’s yeast Saccharomyces cerevisiae, C. albicans also harbors a larger set of genes that have no clear counterparts in other organisms. These “orphan” genes are thought to underlie many of the traits that distinguish it as a pathogen, including its ability to switch between yeast and filamentous growth forms and to colonize wildly different environments within the human body.2PubMed. Comparative genomics of yeast species: new insights into their biology
The CUG Codon Anomaly
Every biology student learns that the genetic code is “universal,” meaning that the same three-letter DNA codons specify the same amino acids across bacteria, plants, animals, and fungi. C. albicans breaks that rule in a small but consequential way. The codon CUG, which in most organisms codes for the amino acid leucine, is read as serine in C. albicans.3PubMed Central. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans The reassignment is not absolute, though. About 97% of the time, the cellular machinery inserts serine at CUG positions, while roughly 3% of the time it inserts the “standard” leucine instead.4PubMed Central. Candida albicans CUG mistranslation is a mechanism to create cell surface variation
That 3% error rate is not a defect. It means a single gene can produce a mixture of slightly different protein variants, because some copies will have serine at a given position and others will have leucine. Research shows this ambiguity generates variation in cell-surface proteins, the very molecules that the immune system uses to recognize the fungus.5PubMed Central. Candida albicans CUG mistranslation is a mechanism to create cell surface variation In effect, C. albicans uses a built-in translation wobble to diversify its outer coat without needing any DNA mutations at all. This is a fundamentally different strategy from how most pathogens generate surface diversity, and it creates a moving target for both the immune system and potential vaccines.
A Genome Built for Instability
If most organisms treat their genome like a carefully maintained library, C. albicans treats its own more like a whiteboard: important, but expected to be rewritten regularly. The organism tolerates large-scale chromosomal changes that would be lethal in many other species, including gaining or losing entire chromosomes (aneuploidy), swapping segments between chromosomes, and converting stretches of heterozygous DNA to homozygous through a process called loss of heterozygosity.6PubMed. Genome plasticity in Candida albicans: A cutting-edge strategy for evolution, adaptation, and survival
Aneuploidy carries a fitness cost under normal growth conditions, slowing cells down and often making them less competitive. But under specific stresses, a cell that happens to have gained an extra copy of the right chromosome can outcompete its neighbors. This is not a hypothetical scenario. Researchers have shown that randomly acquired aneuploidies sometimes enable C. albicans to resist antifungal drugs it has never encountered before, a phenomenon called cross-adaptation.7PubMed Central. Aneuploidy Enables Cross-Adaptation to Unrelated Drugs The organism essentially plays a numbers game: genomic instability produces many losers but occasionally generates exactly the variant that survives a new threat.
Loss of heterozygosity is another major engine of change. When one chromosome copy overwrites the other across a region, previously masked recessive alleles become exposed. Stress accelerates this process dramatically. Oxidative stress, heat, and antifungal drug exposure all increase LOH rates, and different stresses produce different types of genomic change. Oxidative stress tends to trigger localized recombination events, while antifungal drugs and high temperature push toward whole-chromosome changes.8PubMed Central. Stress alters rates and types of loss of heterozygosity in Candida albicans This means the host environment itself, through the immune system’s oxidative attacks and fever responses, may inadvertently accelerate the pathogen’s evolution.
Researchers have proposed that this pattern reflects a concerted adaptation strategy rather than random decay. Because C. albicans lacks meiosis, the conventional engine of genetic recombination, stress-induced genome reshuffling serves as a substitute mechanism for generating diversity under pressure.9Seminars in Cell & Developmental Biology. Ploidy variation as an adaptive mechanism in human pathogenic fungi
Repetitive DNA as a Source of Rearrangement
Much of C. albicans’ genomic plasticity traces to specific repetitive DNA elements scattered across its chromosomes. An extensive catalog of long repeat sequences, ranging from about 65 to nearly 6,500 base pairs, has been linked to copy number variation, loss of heterozygosity, and chromosomal inversions. These repeats are not confined to a single strain; they drive rearrangements across diverse clinical, environmental, and lab-evolved isolates.10PubMed Central. Genome plasticity in Candida albicans is driven by long repeat sequences
One particularly well-studied family is the major repeat sequence, or MRS, which appears at least once on every chromosome except one. MRS elements act as hot spots for chromosome translocations, where arms from two different chromosomes get swapped. They also expand and contract internally, changing the apparent length of the chromosome they sit on. Because MRS copies on different chromosomes, and even on the two copies of the same chromosome, often differ in size, they are a constant source of karyotypic variation visible under laboratory analysis.11PubMed Central. Effect of the major repeat sequence on chromosome loss in Candida albicans This helps explain why clinical isolates of C. albicans can look so different from one another at the chromosome level even when they belong to the same species.
The Parasexual Cycle
C. albicans does not undergo meiosis, the process by which most sexually reproducing organisms halve their chromosome number and shuffle genes between parental copies. For years this led to the assumption that it was strictly clonal. That turned out to be wrong, though not in the way anyone expected. Instead of meiosis, C. albicans uses a parasexual cycle. Two diploid cells fuse to form a tetraploid (four copies of each chromosome), and then the tetraploid gradually sheds chromosomes in a concerted but non-meiotic process until it returns to roughly diploid DNA content.12PLoS Biology. The Parasexual Cycle in Candida albicans Provides an Alternative Pathway to Meiosis for the Formation of Recombinant Strains
The chromosome loss during this return to diploidy is not entirely random. Some recombination does occur, dependent on Spo11, a protein normally associated with meiotic recombination in other organisms.13PubMed Central. The Parasexual Lifestyle of Candida albicans This suggests that the parasexual program may have evolved from a meiotic ancestor and retained some of its recombination machinery even after abandoning the rest. The outcome is a low but real level of genetic mixing between strains, without a conventional sexual cycle.
White-Opaque Switching and Mating-Type Genetics
One of the most striking DNA-level controls on C. albicans behavior is the white-opaque switching system. Cells can toggle between two stable states, “white” and “opaque,” that differ in shape, gene expression, metabolism, and interaction with the immune system. Opaque cells are the mating-competent form, while white cells are better at evading certain immune defenses. The switch is not triggered by mutation; it is epigenetic, meaning it involves changes in how genes are read rather than changes in the DNA sequence itself. Chromatin modifications and non-coding RNA both contribute to regulating these morphological transitions.14PubMed Central. On and Off: Epigenetic Regulation of C. albicans Morphological Switches
There is, however, a hard genetic prerequisite. White-opaque switching only occurs in cells that are homozygous at the mating-type locus (carrying two copies of the same mating type, either a/a or alpha/alpha). Standard heterozygous a/alpha strains, which make up the majority of clinical isolates, do not switch. Studies of clinical isolates that can switch have confirmed that all of them had become homozygous at the mating-type locus, often through the very loss-of-heterozygosity mechanisms described earlier.15PubMed Central. In Candida albicans, white-opaque switchers are homozygous for mating type Researchers have also identified transcription factors, including Rfg1, Brg1, and Efg1, that act as repressors of the opaque state in heterozygous strains. When any of these are deleted, even a/alpha cells gain the ability to switch.16PLoS Biology. White-Opaque Switching in Natural MTLu/a Isolates of Candida albicans: Evolutionary Implications for Roles in Host Adaptation, Pathogenesis, and Sex
How DNA Changes Drive Drug Resistance
The genomic flexibility of C. albicans has direct clinical consequences, most urgently in antifungal drug resistance. The two major classes of antifungals, azoles and echinocandins, each face distinct DNA-level resistance mechanisms.
Azole drugs target the product of the ERG11 gene, an enzyme involved in building the fungal cell membrane. Point mutations in ERG11 can reduce the drug’s ability to bind its target while still allowing the enzyme to function. A systematic study of clinically derived ERG11 mutations found that single amino acid changes at positions like Y132F, K143R, and G464S each produced at least a fourfold increase in resistance to fluconazole, a widely used azole. Combinations of two mutations pushed resistance even further.17PubMed Central. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans Beyond point mutations, cells can also gain extra copies of the ERG11 gene by duplicating chromosome 5 or forming an abnormal chromosome structure, flooding the cell with enough target enzyme to overwhelm the drug.
Echinocandin resistance works through a parallel logic applied to a different gene. Echinocandins inhibit a cell-wall-building enzyme encoded by FKS1. Mutations in two short conserved regions of FKS1 are responsible for nearly all observed echinocandin resistance. In one large study, the serine at position 645 was the most commonly altered residue, with the S645P substitution alone accounting for the majority of resistant isolates.18PubMed Central. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1 These mutations come with a trade-off: resistant strains carrying homozygous FKS1 mutations show reduced enzyme activity and compensate by thickening their cell walls with extra chitin.19PubMed Central. Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance They pay a fitness cost in normal growth, but gain survival when the drug is present.
Candidalysin and Other Virulence Genes
C. albicans is one of the few fungi known to produce a true cytolytic toxin, called candidalysin, that directly damages host cells. The toxin is encoded within a larger gene called ECE1, which produces a precursor protein of 271 amino acids. Candidalysin itself is a discrete peptide hidden within that precursor, released by processing after translation.20PubMed Central. Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence The gene is strongly turned on during hyphal growth, the invasive filamentous form, linking toxin production directly to the tissue-penetrating phase of infection.21PubMed Central. Functional analysis of the Candida albicans ECE1 Promoter
Mitochondrial function also intersects with virulence in ways that would not be obvious from the nuclear genome alone. A gene called GOA1 encodes a protein that localizes to mitochondria under stress conditions. When GOA1 is deleted, the resulting mutant cells have defective respiration and reduced mitochondrial membrane potential, making them unable to drive normal energy production. These mitochondrial deficits correlate with heightened sensitivity to oxidative stress, poor survival inside human immune cells called neutrophils, and loss of virulence in infection models.22PubMed Central. Goa1p of Candida albicans localizes to the mitochondria during stress and is required for mitochondrial function and virulence
DNA-Based Diagnostics
Identifying C. albicans in a clinical setting has traditionally relied on culture, which is slow and often insensitive, particularly for bloodstream infections where fungal cells may be present at low numbers. DNA-based methods offer a faster alternative. The internal transcribed spacer (ITS) region of ribosomal DNA is a common target for fungal identification because it is present in all fungi but varies enough between species to distinguish them. Amplifying the ITS region from a clinical sample with universal fungal primers yields a product that can be sequenced or sized to confirm the species.23Journal of Taibah University for Science. Molecular diagnosis of Candida albicans using real-time polymerase chain reaction of a CaYST1 gene
Quantitative PCR methods targeting the ITS2 subregion have been developed specifically for detecting C. albicans in human blood, the scenario most relevant for diagnosing candidemia. One validated assay achieved a detection limit of about 10 colony-forming units per milliliter of spiked blood, with high efficiency and linearity across dilutions.24PubMed Central. A Real Time PCR strategy for the detection and quantification of Candida albicans in human blood Cutting diagnosis time from the days required for culture to hours with PCR has obvious value in a clinical setting where delayed treatment of candidemia increases mortality.
CRISPR and the Challenge of Engineering a Diploid
For decades, doing genetics in C. albicans was painfully slow. Because the organism is diploid, knocking out a gene requires disrupting both copies. Because it has no meiosis, you cannot simply cross two strains to combine mutations. And because it does not maintain stable plasmids (circular DNA molecules used as genetic tools in many other organisms), introducing foreign DNA is more difficult than in model systems. CRISPR technology has transformed this landscape. A purpose-built CRISPR system for C. albicans enables researchers to mutate both copies of a target gene simultaneously, isolating homozygous knockouts without needing selectable drug-resistance markers.25PubMed Central. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families
Refinements have come quickly. A transient CRISPR-Cas9 approach delivers the editing machinery without permanently integrating it into the genome, reducing the risk of off-target effects and simplifying downstream analysis.26PubMed Central. Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System A further optimized system eliminates the need for molecular cloning entirely, leaves no permanent markers behind, and supports knocking out two unrelated genes in a single transformation step. This system is also compatible with high-throughput workflows, opening the door to building a complete gene-knockout library for C. albicans, something that has existed for baker’s yeast for years but was previously impractical for this pathogen.27PubMed Central. An Efficient, Rapid, and Recyclable System for CRISPR-Mediated Genome Editing in Candida albicans
Non-Coding RNA During Infection
The protein-coding genes in C. albicans tell only part of the story. A growing body of work has cataloged long non-coding RNAs (lncRNAs), stretches of RNA that do not encode proteins but influence gene expression and cellular behavior. During epithelial infection, the number of lncRNAs whose expression changes increases as the infection progresses, and hundreds of these are specific to the infection process rather than generic stress responses. Some of these infection-specific lncRNAs cluster into gene-expression modules enriched for functions directly related to causing disease, including pathogenesis, host adhesion, and filamentous growth.28Nature Communications. The long non-coding RNA landscape of Candida yeast pathogens This layer of regulation means that focusing only on protein-coding genes will miss important aspects of how C. albicans coordinates its attack on host tissue. The non-coding genome, long dismissed as junk or noise in many organisms, is an active participant in this pathogen’s infectious program.